INITIAL RESPONSES TO TEZEPELUMAB IN A COMPLEX SEVERE ASTHMA POPULATION

被引：1
|
作者：
Berrar-Torre, I [1 ]
Stead, R. [1 ]
Lawless, E. [1 ]
Statescu, I [1 ]
Campbell, E. [1 ]
Mamo, S. [1 ]
Brennan, V [1 ]
Patel, P. H. [1 ]
机构：
[1] Royal Brompton Hosp, London, England
来源：
THORAX | 2023年 / 78卷 / SUPPL_4期
关键词：
D O I：
10.1136/thorax-2023-BTSabstracts.279
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P127
引用
收藏
页码：A184 / A184
页数：1
相关论文
共 50 条
  • [21] Clinical Responses to Tezepelumab in Patients With Severe, Uncontrolled Asthma, and a History of Nasal Polyps From the NAVIGATOR Study
    Lugogo, N. L.
    Peters, A. T.
    Chupp, G. L.
    Wechsler, M. E.
    Caveney, S.
    Martin, N.
    Parikh, B.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [22] Population pharmacokinetic and exposure-response analyses to support fixed dosing of tezepelumab in patients with severe asthma
    Zheng, Yanan
    Guan, Ye
    Gao, Yuying
    Liu, Lu
    Abuqayyas, Lubna
    Hellqvist, Asa
    Bowen, Karin
    Colice, Gene
    Macdonald, Alexander
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [23] Clinical Responses to Treatment with Tezepelumab Among Patients with Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Lugogo, N. L.
    Ambrose, C. S.
    Colice, G.
    Kmita, K.
    Cook, B.
    Ponnarambil, S.
    Ackert, J. Llanos
    Menzies-Gow, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [24] Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction
    Israel, Elliot
    Castro, Mario
    Ambrose, Christopher S.
    Llanos, Jean-Pierre
    Molfino, Nestor A.
    Martin, Nicole L.
    Ponnarambil, Sandhia S.
    Martin, Neil
    ERJ OPEN RESEARCH, 2024, 10 (06)
  • [25] Tezepelumab for asthma
    Nolasco, Santi
    Pelaia, Corrado
    Scioscia, Giulia
    Campisi, Raffaele
    Crimi, Claudia
    DRUGS OF TODAY, 2022, 58 (12) : 591 - 603
  • [26] Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma
    Pelaia, Corrado
    Pelaia, Giulia
    Crimi, Claudia
    Maglio, Angelantonio
    Gallelli, Luca
    Terracciano, Rosa
    Vatrella, Alessandro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [27] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma and Fungal Sensitization
    Corren, Jonathan
    Mathur, Sameer K.
    Carr, Tara F.
    Wardlaw, Andrew J.
    Caminati, Marco
    Martin, Nicole
    Ponnarambil, Sandhia
    Lindsley, Andrew W.
    Spahn, Joseph D.
    Martin, Neil
    Geffen, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB97 - AB97
  • [28] Indirect comparison of dupilumab versus tezepelumab in patients with severe asthma
    Chapman, Kenneth R.
    Guyot, Patricia
    Bourhis, Francois
    Msihid, Jerome
    Nair, Radhika
    Nag, Arpita
    Hardin, Megan
    Jacob-Nara, Juby
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 560 - 560
  • [29] Transcription Marker Development in Patients with severe Asthma treated with Tezepelumab
    Ulrich-Merzenich, G.
    Shcherbakova, A.
    Biener, L.
    Pizarro, C.
    Skowasch, D.
    PNEUMOLOGIE, 2024, 78 : S11 - S11
  • [30] The potential promise and challenge for tezepelumab as a biologic therapy for severe asthma
    Williams, Dennis M.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (05): : 581 - 583
12345